Kleopas Kleopa

Dr. Kleopas A.  Kleopa, MD, PhD, FAAN, FEAN, is a Professor and Senior Consultant Neurologist at the Cyprus Institute of Neurology and Genetics (CING). He studied medicine and trained in neurology and neuromuscular disorders in Germany and the USA. Dr. Kleopa has a long track record as a clinician-scientist with extensive expertise in neurological and neuromuscular disorders, neuroscience, and gene therapy. He coordinates the Center for Neuromuscular Disorders delivering multidisciplinary clinical care and providing cutting edge therapeutics. Dr. Kleopa also holds the position of Head of Neuroscience Department and Coordinator of the Neuroscience MSc/PhD Graduate Program at CING. His translational research has made significant contributions to the understanding of neurological disease mechanisms focusing on neurogenetic, neuroinflammatory and neuromuscular disorders and to the development of innovative cell-targeted gene therapies for inherited neuropathies and leukodystrophies, with results currently being developed for clinical translation in collaboration with industry. His work has been published in more than 125 peer-reviewed high-impact scientific papers and has been recognized by numerous prestigious Awards, including the European Academy of Neurology Investigator Award and the Cyprus National Distinguished Researcher Award. He is a member of numerous professional Societies, and serves as Board Member of the International Charcot-Marie-Tooth and Related Disorders Consortium (CMTR), and in Scientific Advisory Boards of Patient Associations, including the American CMT Association, the Gilbert Foundation Neurofibromatosis-1 Gene Therapy Initiative, and the PMD Foundation. He also co-chairs the joint Working Group on Gene Therapies of the European Reference Networks ERN EURO-NMD, RND and EpiCare, as well as the ERN-RND Working group on Leukodystrophies and the ERN-EURO-NMD Working Group on Neuropathies.